Biozentrum, University of Basel, Basel, Switzerland.
Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
mBio. 2021 Feb 9;12(1):e03482-20. doi: 10.1128/mBio.03482-20.
The widespread use of antibiotics promotes the evolution and dissemination of resistance and tolerance mechanisms. To assess the relevance of tolerance and its implications for resistance development, we used evolution and analyzed the inpatient microevolution of , an important human pathogen causing acute and chronic infections. We show that the development of tolerance precedes and promotes the acquisition of resistance , and we present evidence that similar processes shape antibiotic exposure in human patients. Our data suggest that during chronic infections, first acquires moderate drug tolerance before following distinct evolutionary trajectories that lead to high-level multidrug tolerance or to antibiotic resistance. Our studies propose that the development of antibiotic tolerance predisposes bacteria for the acquisition of resistance at early stages of infection and that both mechanisms independently promote bacterial survival during antibiotic treatment at later stages of chronic infections. Over the past decades, pan-resistant strains of major bacterial pathogens have emerged and have rendered clinically available antibiotics ineffective, putting at risk many of the major achievements of modern medicine, including surgery, cancer therapy, and organ transplantation. A thorough understanding of processes leading to the development of antibiotic resistance in human patients is thus urgently needed. We show that drug tolerance, the ability of bacteria to survive prolonged exposure to bactericidal antibiotics, rapidly evolves in the opportunistic human pathogen upon recurrent exposures to antibiotics. Our studies show that tolerance protects against different classes of antibiotics and that it generally precedes and promotes resistance development. The rapid evolution of tolerance during treatment regimens may thus act as a strong driving force to accelerate antibiotic resistance development. To successfully counter resistance, diagnostic measures and novel treatment strategies will need to incorporate the important role of antibiotic tolerance.
抗生素的广泛使用促进了耐药性和耐受性机制的进化和传播。为了评估耐受性的相关性及其对耐药性发展的影响,我们使用进化分析了一种重要的人类病原体 的住院患者微进化,该病原体引起急性和慢性感染。我们表明,耐受性的发展先于并促进了耐药性的获得,并且我们提供了证据表明,类似的过程塑造了人类患者中抗生素暴露的情况。我们的数据表明,在慢性感染期间, 首先获得中度药物耐受性,然后遵循不同的进化轨迹,导致高水平的多药耐受性或抗生素耐药性。我们的研究表明,抗生素耐受性的发展使细菌在感染的早期阶段更容易获得耐药性,并且这两种机制都独立地促进了慢性感染后期抗生素治疗期间细菌的存活。在过去的几十年中,主要细菌病原体的泛耐药菌株已经出现,并使临床上可用的抗生素失效,使许多现代医学的重大成就面临风险,包括手术、癌症治疗和器官移植。因此,迫切需要深入了解导致人类患者抗生素耐药性发展的过程。我们表明,在机会性病原体 中,细菌在反复暴露于抗生素时能够快速进化出药物耐受性,从而能够在长时间接触杀菌抗生素时存活下来。我们的研究表明,耐受性可保护 免受不同类别的抗生素的影响,并且通常先于并促进耐药性的发展。因此,治疗方案中耐受性的快速进化可能是加速抗生素耐药性发展的强大驱动力。为了成功应对耐药性,诊断措施和新的治疗策略将需要纳入抗生素耐受性的重要作用。